Prolonged regression of metastatic leptomeningeal breast cancer that has failed conventional therapy: A case report and review of the literature

Journal of Breast Cancer

Volumn 16, Issue 1, 2013, Pages 122-126

  Vincent, Andrew ^a   Lesser, Glenn ^a   Brown, Doris ^a   Vern Gross, Tamara ^a   Metheny Barlow, Linda ^a   Lawrence, Julia ^a   Chan, Michael ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bevacizumab; Breast neoplasms; Capecitabine; Meningeal neoplasms

Indexed keywords

BEVACIZUMAB; CAPECITABINE;

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CHEMOTHERAPY; FEMALE; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; INFERIOR CEREBELLAR PEDUNCLE; INTENSITY MODULATED RADIATION THERAPY; MENINGEAL METASTASIS; MENINX DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PREMENOPAUSE; SKIN TINGLING; TEMPORAL LOBE; TREATMENT RESPONSE;

EID: 84876189505     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2013.16.1.122     Document Type: Article

References (15)

1. Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 1983;52:2349-54.
2. de la Monte SM, Hutchins GM, Moore GW. Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma. Am J Med 1984;76:11-7.
3. Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, et al. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg 2011;114:1585-91.
4. Hermann B, Hültenschmidt B, Sautter-Bihl ML. Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis. Strahlenther Onkol 2001;177:195-9.
5. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759-72.
6. Peroukides S, Onyenadum A, Starakis I, Koutras A, Makatsoris T, Bouboukas G, et al. Prolonged survival of neoplastic meningitis from breast cancer with letrozole and intrathecal methotrexate: a case report. J Neurooncol 2011;101:509-11.
7. Ferrario C, Davidson A, Bouganim N, Aloyz R, Panasci LC. Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer. Ann Oncol 2009;20:792-5.
8. Stemmler HJ, Mengele K, Schmitt M, Harbeck N, Laessig D, Herrmann KA, et al. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Anticancer Drugs 2008;19:832-6.
9. Clatot F, Philippin-Lauridant G, Ouvrier MJ, Nakry T, Laberge-Le-Couteulx S, Guillemet C, et al. Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy. J Neurooncol 2009;95:421-6.
10. Jaeckle KA, Phuphanich S, Bent MJ, Aiken R, Batchelor T, Campbell T, et al. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer 2001;84:157-63.
11. Ekenel M, Hormigo AM, Peak S, Deangelis LM, Abrey LE. Capecitabine therapy of central nervous system metastases from breast cancer. J Neurooncol 2007;85:223-7.
12. Giglio P, Tremont-Lukats IW, Groves MD. Response of neoplastic meningitis from solid tumors to oral capecitabine. J Neurooncol 2003;65:167-72.
13. Rogers LR, Remer SE, Tejwani S. Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy. Neuro Oncol 2004;6:63-4.
14. Tham YL, Hinckley L, Teh BS, Elledge R. Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report. Clin Breast Cancer 2006;7:164-6.
15. Shigekawa T, Takeuchi H, Misumi M, Matsuura K, Sano H, Fujiuchi N, et al. Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report. Breast Cancer 2009;16:88-92.